The plan involves stockpiling a limited supply of the items so they remain free to the roughly 30 million uninsured adults as the U.S. transitions out of the pandemic’s crisis era, four people familiar with the matter told the news outlet. The nation’s public health emergency is set to end May 11, with costs for tests, vaccines and treatments to shift to the commercial market beginning in the second half of the year.
“We know that the end of the COVID-19 public health emergency is not the end of our work on COVID-19,” a senior administration official told Politico. “It remains a public health priority, and a lot of people will still need these treatments.”
The tentative plan aims to keep COVID-19 care free for the uninsured potentially through the summer of 2024. Administration officials say the plan is still in its early stages and may change. Officials told Politico it is meant as a temporary bridge to protect access and give the Biden administration more time to make the case for additional funding.
Other options health officials are exploring include extending a partnership with pharmacies to provide free COVID-19 testing into 2024. On Feb. 15, Moderna promised its vaccines would remain available at no cost to Americans, regardless of insurance status.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
